News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Hagop Kantarjian: Hyper-CVD + venetoclax achieves CR/CRi rate of 57% in heavily treated relapsed/refractory Acute Lymphoblastic Leukemia
Hagop Kantarjian/ mdanderson.org
Jan 18, 2024, 11:27

Hagop Kantarjian: Hyper-CVD + venetoclax achieves CR/CRi rate of 57% in heavily treated relapsed/refractory Acute Lymphoblastic Leukemia

Hagop Kantarjian, Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, shared on X:

“Hyper-CVD + venetoclax achieves CR/CRi rate of 57% in heavily treated relapsed/refractory Acute Lymphoblastic Leukemia (R/R ALL). Study now amended to add navitoclax (BCL-xL inhibitor).”

Hagop Kantarjian: Hyper-CVD + venetoclax achieves CR/CRi rate of 57% in heavily treated relapsed/refractory Acute Lymphoblastic Leukemia

Read further.
Source: Hagop Kantarjian/X

 

Acute Lymphoblastic Leukemia BCL-XL inhibitor cancer Hagop Kantarjian MD Anderson Cancer Center navitoclax OncoDaily Oncology venetoclax
Special Coverage
Blog
Feb 21, 2025, 12:46
Eric Bouffet: Amazing Webinar with the African Francophone Group of Pediatric Oncology
Blog
Feb 21, 2025, 12:41
Aleix Prat takes on the role of Chair of the Advisory Board at ONA Therapeutics
Blog
Feb 21, 2025, 12:39
Clinical Trials in Europe: Key Trends and Issues - Lung Cancer Europe
Blog
Feb 21, 2025, 12:29
The launch of the Access Cancer Treatment for Children initiative - Childhood Cancer International
Blog
Feb 21, 2025, 11:52
Zainab Shinkafi-Bagudu: Exploring collaborations in cancer care with the Indian High Commission in Abuja
Blog
Feb 21, 2025, 11:51
Integrative medicine for cancer-related pain and anxiety/depression - Society for Integrative Oncology
Insight
Feb 21, 2025, 11:40
Zoë Mullan: The launch of our much-anticipated Commission on medical oxygen security
Science
Feb 21, 2025, 11:36
Myeloma Paper of the Day, February 21st, suggested by Robert Orlowski
Dialogues
Feb 21, 2025, 11:29
HPV Self-Collection for Cervical Cancer: Dr. Kay's Insights
Science
Feb 21, 2025, 11:03
George Vlachogiannis: A growing CRC burden among younger individuals in high socio-demographic index regions
Blog
Feb 21, 2025, 11:02
Divya Sachdev: Building a future where every child, no matter where they live, has a fair chance at survival
Blog
Feb 21, 2025, 10:55
Giuseppe Curigliano: Mourning the untimely passing of Giovanni Scambia - a visionary leader in European gynecologic oncology